Cellular Therapy Lab Software

The University of Texas Health Science Center at San Antonio (UTHSA) is soliciting proposals under solicitation 745-27-P07 for a comprehensive Cellular Therapy transplant program platform. The required software must enable the documentation of processing actions, policy enforcement, equipment and supply monitoring, and audits. The solution must support autologous, allogeneic, CAR-T, and TIL workflows while maintaining chain-of-identity and chain-of-custody. Furthermore, the platform must integrate with EPIC and other enterprise systems and comply with strict regulatory environments, including HIPAA, FERPA, FDA considerations, state privacy laws, and emerging AI regulations. The contract is for an initial three-year term with the possibility of two additional one-year renewals. Award selection is based on the most advantageous proposal, with scoring weighted toward the quality of goods and services, cost, reputation, and the extent to which the solution meets university needs. Proposers must adhere to Texas government codes regarding non-boycott of Israel and non-discrimination against firearm entities, and may be required to obtain TX-RAMP Certification Level II. Payment is set at NET 30 days via ACH or Single-Use Account cards, and the university does not guarantee any specific volume of services. All proposals must be submitted electronically through the Euna procurement portal by November 17, 2026.